ANDA 75542, held by Baxter Hlthcare Corp. Inamrinone Lactate.
As of Nov 15, 2026, ANDA 75542 (Amrinone Lactate), held by Baxter Hlthcare Corp, was first approved by FDA on May 10, 2000, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 10, 2000 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Amrinone LactateEQ 5MG BASE/ML ยท injectable;injection | Inamrinone Lactate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
